{
    "2021-10-26": [
        [
            {
                "time": "2023-10-26",
                "original_text": "安图生物前三度营收、净利润双增，今日股价快速涨停",
                "features": {
                    "keywords": [
                        "安图生物",
                        "营收",
                        "净利润",
                        "涨停"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "体外诊断"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-26",
                "original_text": "安图生物：专注于体外诊断领域，暂无在其他领域拓展的规划",
                "features": {
                    "keywords": [
                        "安图生物",
                        "体外诊断",
                        "专注"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "体外诊断"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-26",
                "original_text": "10月26日安图生物涨停分析：新冠检测，体外诊断，医疗器械概念热股",
                "features": {
                    "keywords": [
                        "安图生物",
                        "新冠检测",
                        "体外诊断",
                        "医疗器械"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "体外诊断",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-26",
                "original_text": "平安证券：给予安图生物增持评级",
                "features": {
                    "keywords": [
                        "平安证券",
                        "安图生物",
                        "增持评级"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "体外诊断"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-26",
                "original_text": "平安证券维持安图生物推荐评级：散发疫情延缓业务恢复，设备铺设稳健推进",
                "features": {
                    "keywords": [
                        "平安证券",
                        "安图生物",
                        "疫情",
                        "业务恢复",
                        "设备铺设"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "体外诊断"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-26",
                "original_text": "中泰证券维持安图生物买入评级：业绩符合预期，疫情反复不改持续恢复增长趋势",
                "features": {
                    "keywords": [
                        "中泰证券",
                        "安图生物",
                        "业绩",
                        "疫情",
                        "增长趋势"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "体外诊断"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-26",
                "original_text": "安图生物涨停三季报验证高景气，本土疫情反扑抗疫概念再度拉升",
                "features": {
                    "keywords": [
                        "安图生物",
                        "三季报",
                        "高景气",
                        "疫情",
                        "抗疫概念"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "体外诊断"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-26",
                "original_text": "国金证券：给予安图生物买入评级",
                "features": {
                    "keywords": [
                        "国金证券",
                        "安图生物",
                        "买入评级"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "体外诊断"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-26",
                "original_text": "国金证券维持安图生物买入评级：业绩超预期，发光、分子诊断新品丰富产品线",
                "features": {
                    "keywords": [
                        "国金证券",
                        "安图生物",
                        "业绩",
                        "发光",
                        "分子诊断",
                        "新品"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "体外诊断"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-26",
                "original_text": "A股异动 | 安图生物(603658.SH)放量涨停 前三季度净利润增近4成",
                "features": {
                    "keywords": [
                        "安图生物",
                        "A股",
                        "放量涨停",
                        "净利润",
                        "增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "体外诊断"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-26",
                "original_text": "安图生物前三度净利润增近4成 入选首批医疗器械标准实施标杆企业",
                "features": {
                    "keywords": [
                        "安图生物",
                        "净利润",
                        "医疗器械",
                        "标杆企业"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "体外诊断",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}